Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft Models by SHOEMAKER, Alex R, MITTEN, Michael J, BAUCH, Joy, MARSH, Kennan, TAHIR, Steven K, XIUFENYANG, TSE, Christin, FESIK, Stephen W, ROSENBERG, Saul H, ELMORE, Steven W, ADICKES, Jessica, ACKLER, Scott, REFICI, Marion, FERGUSON, Debra, OLEKSIJEW, Anatol, O'CONNOR, Jacqueline M, BAOLE WANG, FROST, David J

Get full text

The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo by Ackler, Scott, Mitten, Michael J., Foster, Kelly, Oleksijew, Anatol, Refici, Marion, Tahir, Stephen K., Xiao, Yu, Tse, Christin, Frost, David J., Fesik, Stephen W., Rosenberg, Saul H., Elmore, Steven W., Shoemaker, Alexander R.

Get full text

ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo by Ackler, Scott, Xiao, Yu, Mitten, Michael J, Foster, Kelly, Oleksijew, Anatol, Refici, Marion, Schlessinger, Sally, Wang, Baole, Chemburkar, Sanjay R, Bauch, Joy, Tse, Christin, Frost, David J, Fesik, Stephen W, Rosenberg, Saul H, Elmore, Steven W, Shoemaker, Alex R

Get full text

Evaluation of Seahorse XF Cell Mito Stress Test for Detection of Mitochondrial Dysfunction Using Prototypical Mitochondrial Toxicants in the PC‐3 Cell Line by Zhang, Jie L, Krause, Caitlin, Ciurlionis, Rita, Sharapova, Tatiana L, Wilsbacher, Julie, Ackler, Scott, Van Vleet, Terry, Liguori, Michael J

Get full text

The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents In Vitro and In Vivo by Chen, Jun, Jin, Sha, Abraham, Vivek, Huang, Xiaoli, Liu, Bernard, Mitten, Michael J., Nimmer, Paul, Lin, Xiaoyu, Smith, Morey, Shen, Yu, Shoemaker, Alexander R., Tahir, Stephen K., Zhang, Haichao, Ackler, Scott L., Rosenberg, Saul H., Maecker, Heather, Sampath, Deepak, Leverson, Joel D., Tse, Chris, Elmore, Steven W.

Get full text

Abstract C249: Detection of tissue and bone marrow clearance of systemically engrafted hematologic tumors by ABT-199 and navitoclax using bioluminescent imaging by Ackler, Scott L., Oleksijew, Anatol, Chen, Jun, Chyla, Brenda J., Clarin, Jerry, Foster, Kelly, McGonigal, Thomas, Mishra, Sasmita, Schlessinger, Sally, Smith, Morey L., Tahir, Stephen K., Leverson, Joel, Souers, Andrew J., Boghaert, Erwin R., Hickson, Jonathan

Get full text

Clearance of systemic hematologic tumors by venetoclax (Abt‐199) and navitoclax by Ackler, Scott, Oleksijew, Anatol, Chen, Jun, Chyla, Brenda J., Clarin, Jerry, Foster, Kelly, McGonigal, Thomas, Mishra, Sasmita, Schlessinger, Sally, Smith, Morey L., Tahir, Stephen K., Leverson, Joel D., Souers, Andrew J., Boghaert, Erwin R., Hickson, Jonathan

Get full text

The Bcl-2 Family Inhibitor ABT-263 Shows Significant Anti-Tumor Efficacy in Models of B Cell Non-Hodgkin's Lymphoma by Shoemaker, Alex R., Mitten, Michael J., Oleksijew, Anatol, O'Connor, Jacqeuline M., Wang, Baole, Ackler, Scott, Joseph, Mary, Zhang, Haichao, Nimmer, Paul, Xiao, Yu, Tse, Christin, Frost, David J., Fesik, Stephen W., Rosenberg, Saul H., Elmore, Steven W.

Get full text

The Bcl-2/Bcl-X(L)/Bcl-w inhibitor, navitoclax, enhances the activity of chemotherapeutic agents in vitro and in vivo by Chen, Jun, Jin, Sha, Abraham, Vivek, Huang, Xiaoli, Liu, Bernard, Mitten, Michael J, Nimmer, Paul, Lin, Xiaoyu, Smith, Morey, Shen, Yu, Shoemaker, Alexander R, Tahir, Stephen K, Zhang, Haichao, Ackler, Scott L, Rosenberg, Saul H, Maecker, Heather, Sampath, Deepak, Leverson, Joel D, Tse, Chris, Elmore, Steven W

Get full text

Antigen nonspecific effect of major histocompatibility complex haplotype on autoantibody levels in systemic lupus erythematosus-prone lpr mice by COHEN, P. L, CREECH, E, NAKUL-AQUARONNE, D, MCDANIEL, R, ACKLER, S, RAPOPORT, R. G, SOBEL, E. S, EISENBERG, R. A

Get full text

Characterization of the PKB/AKT Pathway in the Role of Tumorigenesis and Transformation of MCF10A Human Mammary Epithelial Cells by Ackler, Scott L

Request full text